Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

Recruiting Observational Study
Neurodegenerative Diseases Dementia
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Monash University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This cohort study aims to determine if a blood test can aid with diagnosing dementia in anyone presenting with cognitive complaints to a single healthcare network. The investigators will measure levels of a brain protein, Neurofilament light chain (Nfl), and assess changes in language using speech tests. Participants will have a single blood test and speech test, and will be followed up at 12-mon…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients presenting to Eastern Health services with a cognitive complaint or potential neurodegenerative disorder Exclusion Criteria: * Prognosis \<12 months * No cognitive complaint * Patients not involved within the single healthcare network
Contacts

Prof. Amy Brodtmann, MBBS, FRACP, PhD, FANZAN

03 9094 9540

amy.brodtmann@monash.edu

CONTACT

Svetlana Ivanic, BSc(Hons)

svetlana.ivanic@monash.edu

CONTACT